Results for this period
Full year1 April 2025–31 March 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
In the domestic mushroom business, cost reductions, firm mushroom prices, the launch of new products and promotional initiatives contributed to results. In the overseas mushroom business, revenue and operating income on a yen-denominated basis were boosted by the weaker yen, while unsuccessful bids, declining demand, weak vegetable market prices and poor sales performance occurred. In the processed products business, retail products, products for restaurants, delicatessens and ready-to-eat meals, mail-order sales and OEM performed well. In the chemical products business, large-scale equipment projects, newly ordered products and advance procurement of imported raw materials and supplies contributed to results. Insurance proceeds of ¥1,915 million were recorded as extraordinary income.
No applicable matters.
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2025–31 March 2026 |
| Net Sales | ¥85,915 million (YoY +3.4%) |
| Operating profit | ¥7,031 million (YoY +6.1%) |
| Ordinary income | ¥8,186 million (YoY +17.7%) |
| Profit attributable to owners of the parent | ¥7,006 million (YoY +57.8%) |
| Net income per share | ¥223.84 |
| Operating Margin | 8.2% |
| Equity ratio | End of the current fiscal period 57.1% / End of previous period 52.8% |
| Total assets | ¥113,726 million |
| Net assets | ¥64,924 million |
| Cash flows from operating activities | ¥10,824 million |
| Cash flows from investing activities | ¥-2,917 million |
| Cash flows from financing activities | ¥-4,420 million |
| Cash and cash equivalents at end of period | ¥18,861 million |
| Full-year earnings forecast | Net Sales ¥88,100 million (YoY +2.5%) / Operating profit ¥7,260 million (YoY +3.3%) / Ordinary income ¥7,650 million (YoY -6.6%) / Net income ¥5,250 million (YoY -25.1%) |
| Annual Dividend Forecast | ¥55.00 → ¥62.00（12.7%） |
| Payout ratio | Fiscal year ending March 2026 24.6% / Forecast for the fiscal year ending March 2027 37.1% |
| Segment revenue | Domestic mushroom business ¥56,077 million (YoY +1.8%), Overseas mushroom business ¥8,236 million (YoY +6.8%), Processed Products Business ¥8,003 million (YoY -1.9%), Chemical Products Business ¥13,598 million (YoY +12.1%) |
| Segment profit | Domestic mushroom business ¥7,242 million (YoY +3.5%), Overseas mushroom business ¥1,147 million (YoY -0.8%), Processed Products Business ¥511 million (YoY +36.5%), Chemical Products Business ¥470 million (YoY +39.2%) |
| Depreciation and amortization | ¥5,157 million |
| Impairment loss | Not applicable (current consolidated fiscal year) |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥5 million, Gain on sale of investment securities ¥254 million, Insurance proceeds received ¥1,915 million / Total extraordinary income ¥2,175 million / Extraordinary loss Loss on sale of fixed assets ¥0 million, Loss on Disposal of Fixed Assets ¥1 million, Impairment Loss on Investment Securities ¥1 million, Loss from fire ¥119 million, Loss on transition to a retirement benefit plan ¥185 million / Total extraordinary loss ¥307 million |
| Disclosure regarding the going concern assumption | No applicable matters. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Not disclosed / Excluded Not disclosed / Company name Not disclosed / Remarks Material changes in the scope of consolidation during the period: No |
| Material subsequent events | No applicable matters. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Whether applicable Yes / Subject person Not disclosed |
| Issued Shares at Period-End | 33,359,040 shares |
| Treasury Shares at Period-End | 2,012,666 treasury shares |
| Factors Behind Changes in Business Performance | In the domestic mushroom business, cost reductions, firm mushroom prices, the launch of new products and promotional initiatives contributed to results. In the overseas mushroom business, revenue and operating income on a yen-denominated basis were boosted by the weaker yen, while unsuccessful bids, declining demand, weak vegetable market prices and poor sales performance occurred. In the processed products business, retail products, products for restaurants, delicatessens and ready-to-eat meals, mail-order sales and OEM performed well. In the chemical products business, large-scale equipment projects, newly ordered products and advance procurement of imported raw materials and supplies contributed to results. Insurance proceeds of ¥1,915 million were recorded as extraordinary income. |
Items this document does not state (4)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the domestic mushroom business, cost reductions, firm mushroom prices, the launch of new products and promotional initiatives contributed to results. In the overseas business, yen-denominated results were boosted by the weaker yen, while demand declined and sales underperformed. In the processed products business, retail products, products for restaurants, delicatessens and ready-to-eat meals, mail-order sales and OEM performed well. In the chemical products business, large-scale equipment projects, newly ordered products and advance procurement of imported raw materials and supplies boosted revenue. Insurance proceeds of ¥1,915 million were also recorded as extraordinary income.